Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Palandri

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2004
Management of acute graft versus host disease (GvHD)Andrea Bacigalupo, Francesca Palandri
Hematological Oncology|August 12, 2016
New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatmentFrancesca Palandri, Giuseppe Auteri, Michele Baccarani
Annals of Hematology|October 22, 2018
Treating early-stage myelofibrosisFrancesca Palandri, Elena Sabattini, Margherita Maffioli
Cells|September 28, 2021
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That MattersLucia Catani, Michele Cavo, Francesca Palandri
Genes|April 3, 2021
The "Vesicular Intelligence" Strategy of Blood CancersDorian Forte, Martina Barone, Francesca Palandri, et al.
Annals of Hematology|October 2, 2020
Is there a gender effect in polycythemia vera?Francesca Palandri, Barbara Mora, Naseema Gangat, et al.
Cancers|October 13, 2021
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future ScenariosFrancesca Palandri, Massimo Breccia, Valerio De Stefano, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 24, 2014
Treatment recommendations for chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Bone Marrow Transplantation|September 20, 2019
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based reviewMario Tiribelli, Francesca Palandri, Emanuela Sant'Antonio, et al.
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2004
Management of acute graft versus host disease (GvHD)Andrea Bacigalupo, Francesca Palandri
Hematological Oncology|August 12, 2016
New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatmentFrancesca Palandri, Giuseppe Auteri, Michele Baccarani
Annals of Hematology|October 22, 2018
Treating early-stage myelofibrosisFrancesca Palandri, Elena Sabattini, Margherita Maffioli
Cells|September 28, 2021
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That MattersLucia Catani, Michele Cavo, Francesca Palandri
Genes|April 3, 2021
The "Vesicular Intelligence" Strategy of Blood CancersDorian Forte, Martina Barone, Francesca Palandri, et al.
Annals of Hematology|October 2, 2020
Is there a gender effect in polycythemia vera?Francesca Palandri, Barbara Mora, Naseema Gangat, et al.
Cancers|October 13, 2021
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future ScenariosFrancesca Palandri, Massimo Breccia, Valerio De Stefano, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 24, 2014
Treatment recommendations for chronic myeloid leukemiaMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Bone Marrow Transplantation|September 20, 2019
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based reviewMario Tiribelli, Francesca Palandri, Emanuela Sant'Antonio, et al.
Cancer Treatment Reviews|August 16, 2011
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CMLGianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Pageof 19